Ironwood Pharmaceuticals | IRWD - Revenu Net

Prix De L'Action
3.04
Variation Quotidienne
-0.19 -5.88%
Mensuellement
-18.93%
Annuel
115.60%
Q1 Prévisions
2.95




Revenu Net Changement Date
Acadia Pharmaceuticals USD 273.57M 201.79M 2025-12
Agios Pharmaceuticals USD -108.04M 4.61M 2025-12
Akebia Therapeutics USD -12.24M 12.78M 2025-12
Almirall EUR 19.58M 7M 2025-12
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
Amarin USD -1.22M 6.51M 2025-12
Ardelyx USD -407K 562K 2025-12
Astellas Pharma JPY 100.38B 21.17B 2025-12
AstraZeneca USD 2.33B 207M 2025-12
Charles River Laboratories USD -276.56M 330.98M 2025-12
Coherus Biosciences USD -37.64M 2.11M 2025-12
Emergent BioSolutions USD -261.3M 78.3M 2023-06
Esperion Therapeutics USD 61.83M 93.16M 2025-12
Exact Sciences USD -19.59M 18.41M 2025-09
Halozyme Therapeutics USD -141.59M 316.82M 2025-12
Incyte USD 299.28M 124.89M 2025-12
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
Lexicon Pharmaceuticals USD -15.53M 2.76M 2025-12
MacroGenics USD -14.16M 30.98M 2025-12
Moderna USD -200M 625M 2025-09
Myriad Genetics USD -7.9M 19.5M 2025-12
Pacira USD 1.64M 3.8M 2025-12
PTC Therapeutics USD -134.96M 150.86M 2025-12
Puma Biotechnology USD 20.32M 24.85M 2024-09
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
Takeda JPY 103.64B 115.44B 2025-12
Ultragenyx Pharmaceutical USD -129M 51.41M 2025-12
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12